. 2011 Dec 20;3(3):463–469. doi: 10.3892/etm.2011.424

Table I.

Peptide candidates for cancer vaccination.

Symbol for peptide	Origin protein	Position of peptide	Amino acid sequence	HLA type
CypB-129	Cyclophilin B	129–138	KLKHYGPGWV	A2, A3sup^a
Lck-246	p56 lck	246–254	KLVERLGAA	A2
Lck-422	p56 lck	422–430	DVWSFGILL	A2, A3sup
MAP-432	ppMAPkkk	432–440	DLLSHAFFA	A2, A26
WHSC2-103	WHSC2	103–111	ASLDSDPWV	A2, A3sup^a, A26
HNRPL-501	HNRPL	501–510	NVLHFFNAPL	A2, A26
UBE-43	UBE2V	43–51	RLQEWCSVI	A2
UBE-85	UBE2V	85–93	LIADFLSGL	A2
WHSC2-141	WHSC2	141–149	ILGELREKV	A2
HNRPL-140	HNRPL	140–148	ALVEFEDVL	A2
SART3-302	SART3	302–310	LLQAEAPRL	A2
SART3-309	SART3	309–317	RLAEYQAYI	A2
SART2-93	SART2	93–101	DYSARWNEI	A24
SART3-109	SART3	109–118	VYDYNCHVDL	A24, A3sup^a, A26
Lck-208	p56 lck	208–216	HYTNASDGL	A24
PAP-213	PAP	213–221	LYCESVHNF	A24
PSA-248	PSA	248–257	HYRKWIKDTI	A24
EGFR-800	EGF-R	800–809	DYVREHKDNI	A24
MRP3-503	MRP3	503–511	LYAWEPSFL	A24
MRP3-1293	MRP3	1293–1302	NYSVRYRPGL	A24
SART2-161	SART2	161–169	AYDFLYNYL	A24
Lck-486	p56 lck	486–494	TFDYLRSVL	A24
Lck-488	p56 lck	488–497	DYLRSVLEDF	A24
PSMA-624	PSMA	624–632	TYSVSFDSL	A24
EZH2-735	EZH2	735–743	KYVGIEREM	A24
PTHrP-102	PTHrP	102–111	RYLTQETNKV	A24
SART3-511	SART3	511–519	WLEYYNLER	A3sup^a
SART3-734	SART3	734–742	QIRPIFSNR	A3sup^a
Lck-90	p56 lck	90–99	ILEQSGEWWK	A3sup^a
Lck-449	p56 lck	449–458	VIQNLERGYR	A3sup^a
PAP-248	PAP	248–257	GIHKQKEKSR	A3sup^a

A3sup, HLA-A3 supertype (A3, A11, A31 and A33). HLA, human leukocyte antigen.